» Articles » PMID: 14625488

Eosinophilic Granuloma of the Orbit: Understanding the Paradox of Aggressive Destruction Responsive to Minimal Intervention

Overview
Date 2003 Nov 20
PMID 14625488
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the findings and outcomes in eosinophilic granuloma (unifocal Langerhans-cell histiocytosis [LCH]) of the orbit and to explain the paradox of aggressive bone destruction responsive to minimal intervention.

Methods: Retrospective, consecutive, interventional case series of patients treated from 1985 to 2001. Minimum inclusion criteria were demonstration of CD1a positivity or Birbeck granules, treatment by a single surgeon, systemic evaluation by a pediatric oncologist, and follow-up of 12 months. A pathogenetic construct was assembled from general LCH concepts and the specific orbital findings.

Results: Seven patients met study criteria. All were male, 2 to 16 years of age. All had eyelid or forehead swelling and osteolytic defects, with symptoms of 2 to 6 weeks' duration. All underwent incisional biopsy, with frozen-section examination suggestive of LCH in 6 of 7 cases. The 2 earliest patients received low-dose irradiation after simple biopsy. The 5 most recent patients had subtotal curettage at the time of biopsy; 4 of 5 received simultaneous intralesional corticosteroid injection. In all cases, systemic evaluation showed no other focus of LCH, reossification was timely, and no local recurrence or additional focus was noted in follow-up of 1 to 17 years.

Conclusions: Transient immune dysfunction may provoke the cytokine-mediated proliferation of pathologic Langerhans cells within the hematopoietic marrow of the anterolateral frontal bone. These cells cause osteolysis through elaboration of interleukin-1 and prostaglandin E2. Corticosteroids can inhibit the mediators. We recommend incisional biopsy, frozen-section provisional diagnosis, subtotal curettage, intralesional corticosteroid instillation, postoperative systemic evaluation, and long-term surveillance.

Citing Articles

Orbital Langerhans Cell Histiocytosis: A Systematic Review of 228 Cases.

Al-Wassiti A, Bani-Saad A, Bani Saad M, Ismail M Cureus. 2024; 16(10):e71059.

PMID: 39525200 PMC: 11543365. DOI: 10.7759/cureus.71059.


Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers.

Alkatan H, Alzahem T, Maktabi A Int Ophthalmol. 2021; 42(4):1221-1232.

PMID: 34727265 DOI: 10.1007/s10792-021-02108-1.


Atypical presentation of isolated orbital Langerhans cell histiocytosis.

Richards N, Young M, Pierson K, Le J, Rong Y Sarcoidosis Vasc Diffuse Lung Dis. 2020; 36(2):167-171.

PMID: 32476950 PMC: 7247102. DOI: 10.36141/svdld.v36i2.7639.


Langerhans cell histiocytosis of the orbit and frontal sinus of the adult woman: A first case report in Poland.

Kostyra K, Kostkiewicz B Surg Neurol Int. 2020; 10:234.

PMID: 31893135 PMC: 6911676. DOI: 10.25259/SNI_140_2019.


Local delivery of corticosteroids in clinical ophthalmology: A review.

Fung A, Tran T, Lim L, Samarawickrama C, Arnold J, Gillies M Clin Exp Ophthalmol. 2019; 48(3):366-401.

PMID: 31860766 PMC: 7187156. DOI: 10.1111/ceo.13702.